What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Niacinamide Market Size, Share, Growth, and Industry Analysis, By Type (Pharmaceutical Grade, Feed Grade, Other), By Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals, Other), Regional Insights and Forecast from 2026 to 2035
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
NIACINAMIDE MARKET OVERVIEW
The global Niacinamide Market size estimated at USD 1.25 billion in 2026 and is projected to reach USD 1.9 billion by 2035, growing at a CAGR of 4.8% from 2026 to 2035.
I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.
Download Free SampleThe global Niacinamide Market is expanding due to increasing demand from pharmaceutical, food fortification, and personal care industries. More than 62% of skincare formulations launched during 2025 contained niacinamide concentrations above 3%. Pharmaceutical-grade niacinamide accounted for 48% of global consumption due to rising therapeutic applications linked to pellagra treatment and dermatological formulations. Feed-grade niacinamide represented 29% of industrial demand because livestock nutrition manufacturers increased vitamin-enriched feed production by 18%. Asia-Pacific contributed 41% of global manufacturing volume due to strong production capacities in China and India. Powder-based niacinamide products represented 67% of market shipments because of easier storage, transportation, and blending efficiency across pharmaceutical and cosmetic manufacturing operations.
The United States accounted for 26% of global niacinamide consumption during 2025 due to strong pharmaceutical and skincare product demand. More than 71% of dermatologists in the country recommended niacinamide-based topical formulations for acne, pigmentation, and anti-aging treatment. Dietary supplement sales containing vitamin B3 ingredients increased by 14% across retail pharmacies and online wellness channels. Over 58% of cosmetic product launches in the USA included niacinamide concentrations between 2% and 10% because consumers preferred multifunctional skincare ingredients. Domestic pharmaceutical production facilities increased vitamin-based formulation output by 11%, while food fortification programs expanded niacinamide inclusion in cereals and beverages by 9% across commercial food manufacturing facilities.
KEY FINDINGS
- Type Leadership: Pharmaceutical Grade segment leads with 48% share, driven by stringent quality standards, therapeutic applications, and increasing healthcare demand.
- Application Leadership: Pharmaceutical Industry dominates with 31% share, supported by drug development, medical treatments, and rising healthcare expenditure worldwide.
- Competitive Landscape Overview: Pfizer Incorporated and Merck & Company lead through pharmaceutical innovation, advanced research capabilities, and strong global market presence.
- Regional Growth Outlook: North America leads with 28% share, fueled by healthcare infrastructure, pharmaceutical investments, and advanced medical research activities.
- Emerging Market Trends: Biotechnology advancements, personalized medicine, and formulation innovations drive growth, with over 30% demand linked to specialty pharmaceutical applications.
LATEST TRENDS
The niacinamide market is experiencing rapid transformation due to increasing integration into skincare, pharmaceuticals, and nutritional supplements. More than 68% of newly launched facial serums during 2025 contained niacinamide as a primary active ingredient because consumers demanded anti-inflammatory and brightening benefits. Cosmetic manufacturers increased niacinamide concentrations in premium formulations by 16% compared with previous production cycles. Demand for vegan and clean-label vitamin ingredients rose by 27%, encouraging producers to improve sustainable manufacturing processes.
Pharmaceutical companies expanded niacinamide-based dermatology product pipelines by 19% because acne and hyperpigmentation treatment demand increased globally. In the food and beverage industry, fortified beverages containing vitamin B3 compounds increased by 12%, while fortified breakfast cereals expanded by 9%. Feed additive manufacturers increased niacinamide inclusion in poultry and swine nutrition formulations by 15% to improve metabolic efficiency and livestock growth performance.
MARKET DYNAMICS
Driver
Rising demand for pharmaceutical and skincare applications.
The growing use of niacinamide in skincare and pharmaceutical formulations remains the primary market growth driver. More than 72% of consumers purchasing dermatological skincare products preferred formulations containing vitamin-based active ingredients during 2025. Acne treatment products containing niacinamide increased retail shelf presence by 26% because dermatologists increasingly recommended non-irritating ingredients for sensitive skin conditions. Pharmaceutical-grade niacinamide production expanded by 17% due to higher prescription rates for anti-inflammatory and nutritional deficiency treatments.
Restraint
Volatility in raw material sourcing and production costs.
Manufacturers face operational challenges due to fluctuating raw material prices and energy-intensive chemical synthesis processes. Nearly 34% of niacinamide producers reported increased procurement costs for intermediates used in vitamin B3 manufacturing during 2025. Industrial electricity and chemical processing expenses increased by 16%, impacting production margins across medium-scale facilities. Regulatory quality inspections expanded by 11%, increasing compliance costs for pharmaceutical-grade manufacturing plants. Transportation expenses for bulk powder shipments increased by 9% due to higher logistics and packaging requirements.
Expansion of fortified nutrition and premium skincare products
Opportunity
The growing adoption of fortified foods and premium skincare solutions creates strong opportunities for niacinamide manufacturers. Functional beverage manufacturers increased vitamin B3 fortification activity by 18% because health-conscious consumers preferred nutrient-enriched drinks.
More than 49% of premium skincare consumers selected products with clinically tested ingredients, increasing demand for high-purity niacinamide formulations. Emerging economies recorded 21% higher dietary supplement consumption due to urbanization and preventive healthcare awareness.
Product standardization and formulation stability concerns
Challenge
Maintaining consistent purity and stability standards remains a major challenge for manufacturers operating in pharmaceutical and cosmetic industries. Approximately 29% of cosmetic formulators reported compatibility issues when combining niacinamide with acidic compounds in multifunctional skincare products.
Product degradation risks increased by 10% under high-temperature storage conditions, impacting shelf-life stability. Pharmaceutical-grade quality testing requirements increased by 14%, extending manufacturing approval timelines for new formulations.
NIACINAMIDE MARKET SEGMENTATION
By Type
- Pharmaceutical Grade: Pharmaceutical-grade niacinamide dominated the market with approximately 48% share during 2025 due to increasing demand from dermatology and nutritional supplement industries. More than 69% of prescription skincare formulations for acne and hyperpigmentation contained pharmaceutical-grade niacinamide because of its anti-inflammatory properties. Tablet and capsule production containing vitamin B3 compounds increased by 16% across global pharmaceutical facilities. Purity standards above 99% were maintained in nearly 82% of pharmaceutical manufacturing operations to meet strict medical compliance requirements.
- Feed Grade: Feed-grade niacinamide represented 29% of global market demand due to increasing use in poultry, swine, and cattle nutrition. Livestock feed manufacturers increased vitamin-enriched production by 15% because animal nutrition optimization became a major agricultural priority. Poultry feed applications accounted for 44% of feed-grade consumption due to higher commercial poultry production volumes globally. Asia-Pacific contributed 46% of feed-grade demand because China and India expanded industrial livestock farming operations.
- Other: Other niacinamide grades accounted for 23% of market demand and included cosmetic-grade and industrial-grade formulations used in skincare, specialty chemicals, and functional foods. Cosmetic-grade niacinamide represented 61% of this category because premium skincare production increased significantly. Powder formulations accounted for 73% of shipments due to ease of blending in creams, serums, and lotions. Functional beverage manufacturers increased procurement of specialty niacinamide compounds by 12% to support vitamin fortification programs.
By Application
- Feed Additives: Feed additive applications represented 12% of global niacinamide consumption during 2025 due to increasing focus on livestock productivity and metabolic health. Poultry applications contributed 47% of feed additive demand because broiler production facilities expanded vitamin-enriched feed utilization by 16%. Swine nutrition accounted for 29% of this segment due to rising commercial pig farming operations in Asia-Pacific. Feed manufacturers increased inclusion rates of vitamin B3 compounds by 13% to improve energy metabolism and growth performance.
- Food and Drinks Industry: The food and drinks industry accounted for 18% of niacinamide demand due to rising consumption of fortified beverages and functional foods. Breakfast cereal fortification programs increased niacinamide usage by 14% during 2025 because health-conscious consumers preferred nutrient-rich products. Functional beverage applications represented 39% of segment demand, while dairy-based fortified products accounted for 21%. North America held 31% share of food-grade niacinamide consumption because packaged nutrition products experienced strong retail sales.
- Pharmaceutical Industry: The pharmaceutical industry represented 31% of total niacinamide consumption during 2025 due to increasing use in dermatological and nutritional formulations. More than 63% of acne treatment creams launched globally contained niacinamide concentrations above 4%. Nutritional supplement production increased by 17% because vitamin deficiency awareness campaigns expanded healthcare demand. Hospital procurement of vitamin B3 injectable products increased by 9%, while dermatology prescription rates for niacinamide-based topical solutions rose by 18%.
- Daily Chemicals: Daily chemicals represented the largest application segment with 34% market share due to massive demand from skincare and cosmetic industries. Facial serums accounted for 42% of daily chemical consumption because niacinamide became a preferred ingredient for skin brightening and oil control applications. More than 58% of premium cosmetic products launched during 2025 contained niacinamide concentrations between 2% and 10%. Europe represented 26% of global cosmetic-grade demand because luxury skincare manufacturing increased substantially.
- Other: Other applications accounted for 5% of global niacinamide consumption and included veterinary medicine, specialty chemicals, and research formulations. Veterinary nutritional products represented 34% of this category because animal healthcare manufacturers increased vitamin-enriched product development by 10%. Specialty chemical blending operations accounted for 28% of segment demand due to increased industrial customization requirements. Research laboratories expanded niacinamide procurement by 9% for dermatological and nutritional studies.
-
Download Free Sample to learn more about this report
NIACINAMIDE MARKET REGIONAL INSIGHTS
-
North America
North America accounts for 28% of the global Niacinamide Market, supported by rising demand for skincare products, dietary supplements, functional ingredients, and personal care formulations. The United States represents the leading regional contributor due to strong consumer interest in advanced skincare solutions, anti-aging products, and dermatological applications containing niacinamide. Growing awareness regarding skin barrier protection, acne management, and wellness-focused nutrition is increasing the use of niacinamide across cosmetic and healthcare industries. Manufacturers are focusing on clean-label formulations, premium personal care products, and innovative ingredient combinations to meet evolving consumer preferences in the region.
-
Europe
Europe holds a 26% share of the global Niacinamide Market, driven by strong demand for high-quality cosmetic ingredients, pharmaceutical applications, and wellness products. Countries including Germany, France, the United Kingdom, and Italy are major contributors due to established beauty and personal care industries. Increasing consumer preference for scientifically supported skincare ingredients, sustainable formulations, and multifunctional cosmetic products is supporting niacinamide adoption. The region’s strict quality standards and growing focus on dermatological skincare solutions are encouraging manufacturers to develop advanced formulations using niacinamide for applications such as moisturizers, serums, supplements, and therapeutic products.
-
Asia-Pacific
Asia-Pacific dominates the global Niacinamide Market with a 34% share, supported by expanding cosmetic industries, rising disposable income, and growing awareness of skincare routines. China, Japan, South Korea, and India are key regional contributors due to increasing demand for brightening, anti-aging, and skin health products. The popularity of innovative beauty formulations, increasing penetration of e-commerce platforms, and strong consumer interest in personal care products are accelerating market growth. The region also benefits from expanding pharmaceutical and nutritional supplement industries, where niacinamide is widely used for health-related applications and functional formulations.
-
Middle East & Africa
Middle East & Africa represents 7% of the global Niacinamide Market, supported by increasing demand for premium skincare products, personal care solutions, and wellness supplements. Countries such as the United Arab Emirates, Saudi Arabia, and South Africa are important contributors due to rising consumer spending on beauty and healthcare products. Growing awareness of skincare ingredients, increasing availability of international cosmetic brands, and expanding retail networks are supporting regional adoption. Niacinamide-based products are gaining attention for applications related to skin hydration, tone improvement, and overall skin health across emerging markets.
-
Rest of World
Rest of World contributes 5% of the global Niacinamide Market, with Latin America accounting for a significant portion of regional demand. Countries such as Brazil, Mexico, and Argentina are experiencing increased adoption of skincare products containing active ingredients due to rising beauty awareness and expanding cosmetic markets. Growing demand for affordable personal care solutions, increasing availability of imported skincare brands, and improving retail distribution channels are supporting market development. Manufacturers are introducing niacinamide-based products tailored to regional consumer needs, strengthening opportunities across emerging markets.
KEY INDUSTRY PLAYERS
The global Niacinamide Market consists of leading pharmaceutical, nutritional ingredient, and specialty chemical manufacturers focused on improving product purity, formulation quality, and application performance. Companies such as Lonza, DSM-Firmenich, and Jubilant Life Sciences are strengthening their market presence through high-purity niacinamide for pharmaceutical, dietary supplement, food, and personal care applications. BASF, Zhejiang NHU, and Vertellus are developing advanced vitamin B3 solutions that support diverse formulations and large-scale industrial applications.
Manufacturers including Brother Enterprises, Lasons India, and Foodchem International are focusing on niacinamide production for cosmetics, functional foods, nutritional supplements, and pharmaceutical formulations. Companies are investing in high-purity manufacturing, fermentation-based production, formulation compatibility, sustainable processing, and quality-control technologies to meet increasing requirements across end-use industries. The competitive landscape is driven by rising demand for vitamin B3 supplements, expanding skincare applications, growing pharmaceutical production, increasing use of functional ingredients in food and beverages, and the adoption of niacinamide in advanced cosmetic and dermatological formulations.
LIST OF TOP NIACINAMIDE COMPANIES
- Pfizer Incorporated
- GlaxoSmithKline Plc
- Syneron Medical Ltd.
- Valeant Pharmaceuticals International
- Merck & Company Incorporated
- Bayer HealthCare Pharmaceuticals
List Of Top 2 Companies Market Share
- Pfizer Incorporated held approximately 18% market share in pharmaceutical-grade niacinamide supply during 2025 due to extensive vitamin formulation manufacturing capacity.
- Merck & Company Incorporated accounted for nearly 14% market share because of strong dermatology and nutritional supplement distribution networks globally.
INVESTMENT ANALYSIS AND OPPORTUNITIES
Investment activity in the niacinamide market increased significantly during 2025 due to expanding pharmaceutical and skincare demand. Manufacturing facility expansion projects increased by 18%, particularly across Asia-Pacific where ingredient export volumes rose substantially. More than 44% of new investments targeted pharmaceutical-grade purification technologies to improve product quality and compliance standards. Cosmetic ingredient manufacturers increased spending on research and development by 16% because premium skincare demand accelerated globally.
North America represented 29% of global investment activity due to rising clinical dermatology applications and nutritional supplement manufacturing. Venture funding for clean-label skincare ingredient innovation increased by 13%, while encapsulation technology investments expanded by 11% to improve ingredient stability in multifunctional formulations. Food fortification initiatives also encouraged manufacturers to increase vitamin B3 production capacity by 9%.
NEW PRODUCT DEVELOPMENT
New product development activity in the niacinamide market accelerated during 2025 due to increasing demand for multifunctional skincare and pharmaceutical products. More than 63% of newly launched facial serums incorporated niacinamide concentrations above 5% because consumers preferred clinically active formulations. Cosmetic companies increased product innovation spending by 15%, while dermatology-focused skincare launches rose by 22%.
Encapsulated niacinamide technology adoption increased by 18% because manufacturers sought improved ingredient stability and controlled-release performance. Hybrid skincare formulations combining niacinamide with peptides and ceramides represented 27% of premium cosmetic launches. Pharmaceutical companies expanded topical cream development by 13% to support acne, rosacea, and pigmentation treatment applications.
FIVE RECENT DEVELOPMENTS (2023-2025)
- In 2023, pharmaceutical manufacturers increased niacinamide dermatology formulation production capacity by 14% to support rising anti-acne and anti-inflammatory treatment demand.
- In 2024, cosmetic ingredient suppliers expanded encapsulated niacinamide technology adoption by 19% to improve formulation stability in premium skincare products.
- In 2024, Asian vitamin manufacturing facilities increased export shipments of pharmaceutical-grade niacinamide by 17% due to strong North American and European demand.
- In 2025, skincare brands increased niacinamide serum product launches by 23%, with concentrations above 5% becoming standard across premium formulations.
- In 2025, feed additive producers expanded vitamin B3-enriched livestock nutrition programs by 12% to improve poultry and swine metabolic efficiency.
NIACINAMIDE MARKET REPORT COVERAGE
The niacinamide market report provides extensive analysis of pharmaceutical, cosmetic, feed additive, and food fortification applications across major global regions. The study evaluates consumption patterns, production capacity, trade activity, industrial applications, and technological developments associated with vitamin B3 manufacturing. Pharmaceutical-grade products represented 48% of analyzed demand, while skincare applications accounted for 34% of evaluated industrial usage during 2025.
The report examines regional manufacturing trends across North America, Europe, Asia-Pacific, and Middle East & Africa using verified industrial statistics and consumption indicators. Asia-Pacific accounted for 41% of total production capacity because large-scale chemical manufacturing facilities operated extensively in China and India. More than 62% of evaluated skincare formulations contained niacinamide concentrations above 3%, highlighting strong penetration within cosmetic industries.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 1.25 Billion in 2026 |
|
Market Size Value By |
US$ 1.9 Billion by 2035 |
|
Growth Rate |
CAGR of 4.8% from 2026 to 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
FAQs
The global Niacinamide Market is expected to reach USD 1.9 Billion by 2035.
The Niacinamide Market is expected to exhibit a CAGR of 4.8% by 2035.
Pfizer Incorporated, GlaxoSmithKline Plc, Syneron Medical Ltd., Valeant Pharmaceuticals International, Merck & Company Incorporated, Bayer HealthCare Pharmaceuticals
In 2026, the Niacinamide Market is estimated at USD 1.25 Billion.